Their findings also seem to suggest that the VDR gene polymorphisms are responsible for susceptibility to cardiovascular complications in CAD and that genetic and epigenetic typification of patients might improve the success rate of vitamin D therapy in small defined subpopulations. This evidence concerns the gene VDR and coronary artery disorder.